Updated Jul 16, 2026
Tardio Jason has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K.
Jason Tardio is the President and COO of Immunic Inc., a clinical-stage biopharmaceutical company focused on developing therapies for chronic inflammatory and autoimmune diseases. He has been involved in the company's operations and strategic direction, contributing to its growth in the biopharmaceutical sector.
| Role | President and COO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-06-05 | IMUX | IMMUNIC, INC. | P — Open-market purchase | 12.5K | $0.79 | $10K |
Jason Tardio is the President and COO of Immunic Inc., a clinical-stage biopharmaceutical company focused on developing therapies for chronic inflammatory and autoimmune diseases. He has been involved in the company's operations and strategic direction, contributing to its growth in the biopharmaceutical sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tardio Jason profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.